Search research articles
Contact Us
Filters
Showing results (91-100 of 129) with videos related to
Page
of 13
Sort By:
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
September 1, 1986
Pharmacokinetics of erythromycin in patients with different degrees of renal impairment
B Disse, U Gundert-Remy, E Weber, et al.
Acta Anaesthesiologica Scandinavica
|
October 1, 1995
Transpulmonary disposition of prilocaine, mepivacaine, and bupivacaine in humans in the course of epidural anaesthesia
D Kietzmann, H Foth, W P Geng, et al.
European Journal of Clinical Pharmacology
|
January 1, 1997
Comparative bioavailability of two vitamin B1 preparations: benfotiamine and thiamine mononitrate
K H Schreeb, S Freudenthaler, S V Vormfelde, et al.
BMJ (Clinical Research Ed.)
|
November 19, 1988
Is there a genetic factor in flecainide toxicity?
J Beckmann, R Hertrampf, U Gundert-Remy, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1989
The influence of the sparteine/debrisoquin phenotype on the disposition of flecainide
G Mikus, A S Gross, J Beckmann, et al.
IARC Scientific Publications
|
December 18, 2002
Expression of cytochrome P450 enzymes in human colon
U Bernauer, R Ellrich, B Heinrich-Hirsch, et al.
Archives of Toxicology
|
October 23, 2016
The importance of protein binding for the in vitro-in vivo extrapolation (IVIVE)-example of ibuprofen, a highly protein-bound substance
H Mielke, E Di Consiglio, R Kreutz, et al.
British Journal of Clinical Pharmacology
|
November 1, 1989
Stereoselective disposition of flecainide in relation to the sparteine/debrisoquine metaboliser phenotype
A S Gross, G Mikus, C Fischer, et al.
European Journal of Clinical Pharmacology
|
January 1, 1983
Intestinal absorption of levodopa in man
U Gundert-Remy, R Hildebrandt, A Stiehl, et al.
European Journal of Clinical Pharmacology
|
January 1, 1981
The clinical pharmacokinetics of buflomedil in normal subjects after intravenous and oral administration
U Gundert-Remy, E Weber, G Lam, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 129) with videos related to
Sort By:
Page
of 13
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
September 1, 1986
Pharmacokinetics of erythromycin in patients with different degrees of renal impairment
B Disse, U Gundert-Remy, E Weber, et al.
Acta Anaesthesiologica Scandinavica
|
October 1, 1995
Transpulmonary disposition of prilocaine, mepivacaine, and bupivacaine in humans in the course of epidural anaesthesia
D Kietzmann, H Foth, W P Geng, et al.
European Journal of Clinical Pharmacology
|
January 1, 1997
Comparative bioavailability of two vitamin B1 preparations: benfotiamine and thiamine mononitrate
K H Schreeb, S Freudenthaler, S V Vormfelde, et al.
BMJ (Clinical Research Ed.)
|
November 19, 1988
Is there a genetic factor in flecainide toxicity?
J Beckmann, R Hertrampf, U Gundert-Remy, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1989
The influence of the sparteine/debrisoquin phenotype on the disposition of flecainide
G Mikus, A S Gross, J Beckmann, et al.
IARC Scientific Publications
|
December 18, 2002
Expression of cytochrome P450 enzymes in human colon
U Bernauer, R Ellrich, B Heinrich-Hirsch, et al.
Archives of Toxicology
|
October 23, 2016
The importance of protein binding for the in vitro-in vivo extrapolation (IVIVE)-example of ibuprofen, a highly protein-bound substance
H Mielke, E Di Consiglio, R Kreutz, et al.
British Journal of Clinical Pharmacology
|
November 1, 1989
Stereoselective disposition of flecainide in relation to the sparteine/debrisoquine metaboliser phenotype
A S Gross, G Mikus, C Fischer, et al.
European Journal of Clinical Pharmacology
|
January 1, 1983
Intestinal absorption of levodopa in man
U Gundert-Remy, R Hildebrandt, A Stiehl, et al.
European Journal of Clinical Pharmacology
|
January 1, 1981
The clinical pharmacokinetics of buflomedil in normal subjects after intravenous and oral administration
U Gundert-Remy, E Weber, G Lam, et al.
Page
of 13